NCT06306092 Promoting Teenage Sleep for Improved Mental Health and School Performance
| NCT ID | NCT06306092 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kristianstad University |
| Condition | Mental Health Issue |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-08-17 |
| Primary Completion | 2028-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2024-08-17 with a primary completion date of 2028-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim of this project is to evaluate the effectiveness of two school-based programs that have the potential to promote adolescent sleep and prevent future depressive symptoms. The programs will be offered to students aged 13-19 at Swedish high schools and upper secondary schools at the classroom level. The students will be compared to teaching as usual (control group).
Eligibility Criteria
Inclusion Criteria: Students in Swedish high schools and upper secondary schools. Exclusion Criteria: \-
Contact & Investigator
Annika Norell, PhD
PRINCIPAL INVESTIGATOR
Örebro University, Sweden
Frequently Asked Questions
Who can join the NCT06306092 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 19 Years, studying Mental Health Issue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06306092 currently recruiting?
Yes, NCT06306092 is actively recruiting participants. Contact the research team at pernilla.garmy@hkr.se for enrollment information.
Where is the NCT06306092 trial being conducted?
This trial is being conducted at Kristianstad, Sweden.
Who is sponsoring the NCT06306092 clinical trial?
NCT06306092 is sponsored by Kristianstad University. The principal investigator is Annika Norell, PhD at Örebro University, Sweden. The trial plans to enroll 3,000 participants.